Phibro Animal Health (NASDAQ:PAHC) Downgraded to “Hold” Rating by StockNews.com

StockNews.com lowered shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a hold rating in a report released on Friday morning.

PAHC has been the topic of several other research reports. Morgan Stanley boosted their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Barclays boosted their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $23.64 on Friday. The company’s 50 day moving average is $22.47 and its 200-day moving average is $22.54. Phibro Animal Health has a 12-month low of $11.98 and a 12-month high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The firm has a market cap of $957.49 million, a P/E ratio of 49.25, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Sell-side analysts predict that Phibro Animal Health will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.03%. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Point72 Asia Singapore Pte. Ltd. purchased a new position in Phibro Animal Health in the 4th quarter worth approximately $29,000. Lazard Asset Management LLC grew its stake in Phibro Animal Health by 2,739.7% in the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock worth $34,000 after buying an additional 1,589 shares in the last quarter. Quantbot Technologies LP purchased a new position in Phibro Animal Health in the 3rd quarter worth approximately $70,000. Virtus Fund Advisers LLC purchased a new position in Phibro Animal Health in the 4th quarter worth approximately $69,000. Finally, Aquatic Capital Management LLC purchased a new position in Phibro Animal Health in the 4th quarter worth approximately $69,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.